Natera, Inc.
Clinical trials sponsored by Natera, Inc., explained in plain language.
-
Blood test could personalize breast cancer treatment, spare some from extra drugs
Disease control Not yet recruitingThis study is testing a personalized approach for people with intermediate-risk, hormone-positive breast cancer. It uses a special blood test to check for tiny signs of cancer. If the test is positive, patients add a targeted drug (CDK4/6 inhibitor) to their standard hormone ther…
Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Blood test could spare women unnecessary radiation after cancer surgery
Knowledge-focused Not yet recruitingThis study is testing whether a blood test that looks for tiny pieces of cancer DNA can help doctors decide which patients need extra radiation treatment after surgery. It will compare outcomes for women who are monitored with the blood test against those who receive standard rad…
Phase: NA • Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC